UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Realworld Effectiveness of Ledipasvir/Sofosbuvir (LDV/SOF) in Treatment-Experienced Cirrhotic Genotype 1 Patients with Chronic Hepatitis C: A Comparative Analysis of Gilead Sponsored Trials with 4 Real-World Cohorts

Journal of hepatology, 2016, Vol.64 (2), p.S797-S797

2016

Volltextzugriff (PDF)

Integrated Analysis of SOF + RBV or LDV/SOF for the Treatment of Genotype 4 Chronic HCV Infection

Journal of hepatology, 2016, Vol.64 (2), p.S769-S769

2016

Volltextzugriff (PDF)

Ledipasvir/Sofosbuvir (LDV/SOF) for 8 Wks in Genotype 1 (GT1) Treatment-Naïve Non-Cirrhotic Patients with HCV Viral Load <6 Million IU/mL (6M); Acomparative Analysis of the Phase-3 ION-3 Data to Real World Effectiveness

Journal of hepatology, 2016, Vol.64 (2), p.S810-S810

2016

Volltextzugriff (PDF)

PPM7 Finding Undiagnosed Patients with Hepatitis C Virus: An Application of Artificial Intelligence to US Ambulatory Electronic Medical Records

Value in health, 2021-06, Vol.24, p.S196-S196

2021

Volltextzugriff (PDF)

Antibiotic prophylaxis for cardiothoracic operations : metaanalysis of thirty years of clinical trials

The Journal of thoracic and cardiovascular surgery, 1992, Vol.104 (3), p.590-599

1992

Volltextzugriff (PDF)

919 ENTECAVIR (ETV) THERAPY IN CHRONIC HEPATITIS B PATIENTS PREVIOUSLY TREATED WITH ADEFOVIR (ADV) WITH INCOMPLETE RESPONSE ON-TREATMENT OR RELAPSE OFF-TREATMENT

Journal of hepatology, 2009, Vol.50, p.S334-S334

2009

Volltextzugriff (PDF)

[518] EFFICACY OF ENTECAVIR AND LAMIVUDINE IN CHRONIC HEPATITIS B PATIENTS WITH ADVANCED FIBROSIS/CIRRHOSIS

Journal of hepatology, 2007, Vol.46, p.S197-S197

2007

Volltextzugriff (PDF)

[483] PRESENCE OF BIOPSY-PROVEN HISTOLOGIC DAMAGE (NECROINFLAMMATION AND FIBROSIS) IS COMMON EVEN WHEN ALT IS LESS THAN 2 × ULN IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)

Journal of hepatology, 2007, Vol.46, p.S184-S184

2007

Volltextzugriff (PDF)

SAT-214 - Realworld Effectiveness of Ledipasvir/Sofosbuvir (LDV/SOF) in Treatment-Experienced Cirrhotic Genotype 1 Patients with Chronic Hepatitis C: A Comparative Analysis of Gilead Sponsored Trials with 4 Real-World Cohorts

Journal of hepatology, 2016, Vol.64 (2), p.S797-S797

2016

Volltextzugriff (PDF)

SAT-242 - Ledipasvir/Sofosbuvir (LDV/SOF) for 8 Wks in Genotype 1 (GT1) Treatment-Naïve Non-Cirrhotic Patients with HCV Viral Load <6 Million IU/mL (6M); Acomparative Analysis of the Phase-3 ION-3 Data to Real World Effectiveness

Journal of hepatology, 2016, Vol.64 (2), p.S810-S810

2016

Volltextzugriff (PDF)

Cost-analysis of imipenem-cilastatin monotherapy compared with clindamycin + aminoglycoside combination therapy for treatment of serious lower respiratory, intra-abdominal, gynecologic and urinary tract infections

Clinical therapeutics, 1992, Vol.14 (1), p.110-121

KRETER, B

1992

Volltextzugriff (PDF)

SAT-159 - Integrated Analysis of SOF + RBV or LDV/SOF for the Treatment of Genotype 4 Chronic HCV Infection

Journal of hepatology, 2016, Vol.64 (2), p.S769-S769

2016

Volltextzugriff (PDF)

Treatment of hospitalized patients with complicated Gram-positive skin and skin structure infections : two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin

Journal of antimicrobial chemotherapy, 1999-08, Vol.44 (2), p.263-273

1999

Volltextzugriff (PDF)

A183 SOFOSBUVIR-BASED ALL-ORAL REGIMENS FOR PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 3 INFECTION: INTEGRATED ANALYSIS OF FIVE CLINICAL STUDIES

Journal of the Canadian Association of Gastroenterology, 2018-03, Vol.1 (suppl_1), p.318-319

2018

Volltextzugriff (PDF)

Eine Langzeittherapie mit Entecavir führt zum Rückgang von Fibrose bei Patienten mit HBeAg(+) und (-) chronischer Hepatitis B: Ergebnisse der Phase III Studien ETV-022, -027 und Studie ETV-901

Zeitschrift für Gastroenterologie, 2009, Vol.47 (9)

2009

Volltextzugriff (PDF)

513 Effects of entecavir and lamivudine on advanced liver fibrosis after 48 weeks of treatment in patients with CHB infection: Results of three pivotal trials

Journal of hepatology, 2006-04, Vol.44, p.S191-S191

2006

Volltextzugriff (PDF)

Ketamine as an Anesthetic Agent for Interventional Radiology

Seminars in interventional radiology, 1987-09, Vol.4 (3), p.183-188

Kreter, Bruce

1987

Volltextzugriff (PDF)

Summary of phase II clinical and laboratory safety experience with Entecavir

Journal of hepatology, 2003-04, Vol.38, p.170-170

2003

Volltextzugriff (PDF)

Guidelines for Therapeutic Interchange

Pharmacotherapy, 1993-05, Vol.13 (3), p.252-256

American College of Clinical Pharmacy

1993

Volltextzugriff (PDF)

Efficacy and tolerability of imipenem-cilastatin versus clindamycin + gentamicin for serious Pelvic infections

Clinical therapeutics, 1992, Vol.14 (1), p.90-96

1992

Volltextzugriff (PDF)

Skin Testing for Anergy

Drug intelligence & clinical pharmacy, 1985-04, Vol.19 (4), p.300-301

1985

Volltextzugriff (PDF)

Abuse of computer graphics

Pharmacotherapy, 1991-01, Vol.11 (2), p.168-170

Kreter, Bruce

1991

Volltextzugriff (PDF)

Antibiotic prophylaxis for cardiothoracic operations. Meta-analysis of thirty years of clinical trials

The Journal of thoracic and cardiovascular surgery, 1992-09, Vol.104 (3), p.590-599

1992

Volltextzugriff (PDF)

Treatment of hospitalized patients with complicated Gram- positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin

Journal of antimicrobial chemotherapy, 1999-10, Vol.44 (4), p.585-585

1999

Volltextzugriff (PDF)

Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection Group

Journal of antimicrobial chemotherapy, 1999-08, Vol.44 (2), p.263-273

1999

Volltextzugriff (PDF)

1 – 25 von 148

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(146)
Mit Volltextzugriff
(122)

Publikationsform

Artikel
(141)
Tagungsberichte
(7)

Sprache

Englisch
(146)
Deutsch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(107)
Technology
(53)
Physical Sciences
(50)
Physics
(50)
Nuclear Science & Technology
(47)
Tungsten
(27)
Materials Science
(24)
Exact Sciences And Technology
(21)
Materials Science, Multidisciplinary
(21)
Physics, Fluids & Plasmas
(19)
Energy
(18)
Physics, Multidisciplinary
(16)
Applied Sciences
(15)
Controled Nuclear Fusion Plants
(15)
Energy. Thermal Use Of Fuels
(15)
Installations For Energy Generation And Conversion: Thermal And Electrical Energy
(15)
Fuels
(12)
Life Sciences & Biomedicine
(12)
Fission Nuclear Power Plants
(11)
Humans
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Realworld Effectiveness of Ledipasvir/Sofosbuvir (LDV/SOF) in Treatment-Experienced Cirrhotic Genotype 1 Patients with Chronic Hepatitis C: A Comparative Analysis of Gilead Sponsored Trials with 4 Real-World Cohorts

Integrated Analysis of SOF + RBV or LDV/SOF for the Treatment of Genotype 4 Chronic HCV Infection

Ledipasvir/Sofosbuvir (LDV/SOF) for 8 Wks in Genotype 1 (GT1) Treatment-Naïve Non-Cirrhotic Patients with HCV Viral Load <6 Million IU/mL (6M); Acomparative Analysis of the Phase-3 ION-3 Data to Real World Effectiveness

PPM7 Finding Undiagnosed Patients with Hepatitis C Virus: An Application of Artificial Intelligence to US Ambulatory Electronic Medical Records

Antibiotic prophylaxis for cardiothoracic operations : metaanalysis of thirty years of clinical trials

919 ENTECAVIR (ETV) THERAPY IN CHRONIC HEPATITIS B PATIENTS PREVIOUSLY TREATED WITH ADEFOVIR (ADV) WITH INCOMPLETE RESPONSE ON-TREATMENT OR RELAPSE OFF-TREATMENT

[518] EFFICACY OF ENTECAVIR AND LAMIVUDINE IN CHRONIC HEPATITIS B PATIENTS WITH ADVANCED FIBROSIS/CIRRHOSIS

[483] PRESENCE OF BIOPSY-PROVEN HISTOLOGIC DAMAGE (NECROINFLAMMATION AND FIBROSIS) IS COMMON EVEN WHEN ALT IS LESS THAN 2 × ULN IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)

SAT-214 - Realworld Effectiveness of Ledipasvir/Sofosbuvir (LDV/SOF) in Treatment-Experienced Cirrhotic Genotype 1 Patients with Chronic Hepatitis C: A Comparative Analysis of Gilead Sponsored Trials with 4 Real-World Cohorts

SAT-242 - Ledipasvir/Sofosbuvir (LDV/SOF) for 8 Wks in Genotype 1 (GT1) Treatment-Naïve Non-Cirrhotic Patients with HCV Viral Load <6 Million IU/mL (6M); Acomparative Analysis of the Phase-3 ION-3 Data to Real World Effectiveness

Cost-analysis of imipenem-cilastatin monotherapy compared with clindamycin + aminoglycoside combination therapy for treatment of serious lower respiratory, intra-abdominal, gynecologic and urinary tract infections

SAT-159 - Integrated Analysis of SOF + RBV or LDV/SOF for the Treatment of Genotype 4 Chronic HCV Infection

Treatment of hospitalized patients with complicated Gram-positive skin and skin structure infections : two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin

A183 SOFOSBUVIR-BASED ALL-ORAL REGIMENS FOR PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 3 INFECTION: INTEGRATED ANALYSIS OF FIVE CLINICAL STUDIES

Eine Langzeittherapie mit Entecavir führt zum Rückgang von Fibrose bei Patienten mit HBeAg(+) und (-) chronischer Hepatitis B: Ergebnisse der Phase III Studien ETV-022, -027 und Studie ETV-901

513 Effects of entecavir and lamivudine on advanced liver fibrosis after 48 weeks of treatment in patients with CHB infection: Results of three pivotal trials

Ketamine as an Anesthetic Agent for Interventional Radiology

Summary of phase II clinical and laboratory safety experience with Entecavir

Guidelines for Therapeutic Interchange

Efficacy and tolerability of imipenem-cilastatin versus clindamycin + gentamicin for serious Pelvic infections

Skin Testing for Anergy

Abuse of computer graphics

Antibiotic prophylaxis for cardiothoracic operations. Meta-analysis of thirty years of clinical trials

Treatment of hospitalized patients with complicated Gram- positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin

Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection Group

Suchergebnisse filtern